Singapore markets closed

Pharmicell Co., Ltd. (005690.KS)

KSE - KSE Delayed Price. Currency in KRW
Add to watchlist
6,250.00-160.00 (-2.50%)
At close: 03:30PM KST
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
60,048,720
56,227,379
60,181,807
51,811,621
37,752,048
Cost of revenue
34,725,816
40,735,416
36,362,213
28,103,650
19,972,757
Gross profit
25,322,904
15,491,963
23,819,594
23,707,970
17,779,291
Operating expenses
Research development
8,148,086
6,544,418
6,884,276
6,994,159
4,308,449
Selling general and administrative
1,945,208
2,966,170
2,413,463
2,550,548
1,508,050
Total operating expenses
16,253,818
14,195,966
14,946,227
15,844,956
10,545,781
Operating income or loss
9,069,086
1,295,997
8,873,367
7,863,014
7,233,510
Interest expense
866,883
866,883
746,199
1,682,921
84,893
Income before tax
12,908,584
4,732,057
5,968,958
9,450,907
5,241,801
Income tax expense
1,154,074
1,154,074
-2,292,811
-
-
Income from continuing operations
12,908,584
3,577,984
8,261,769
9,450,907
5,241,801
Net income
12,908,584
3,577,984
8,261,769
9,450,907
5,241,801
Net income available to common shareholders
12,908,584
3,577,984
8,261,769
9,450,907
5,241,801
Basic EPS
98.00
-
138.00
158.00
87.00
Diluted EPS
98.00
-
138.00
158.00
87.00
Basic average shares
59,989
-
59,868
59,816
59,946
Diluted average shares
59,989
-
59,868
59,816
59,946